The British Business Bank has agreed to make a £100 million commitment to Apposite Healthcare Growth I, a fund investing to support the growth of health technology companies, primarily in the UK. This will be the British Business Bank’s largest fund commitment to date and is the Bank’s first commitment to Apposite Capital.

Apposite Capital is a specialist healthcare and life sciences investor. Apposite Healthcare Growth I will invest in innovative companies across medical products, diagnostics, life sciences tools, digital health, and pharmaceutical outsourcing services.

The fund aims to address the shortage of scale-up capital for UK life sciences companies approaching a growth inflection, which aligns with the Bank’s strategy to create deeper pools of scale up funding.